| Real-world data on upadacitinib in the treatment of atopic dermatitis are limited. |
| Upadacitinib demonstrated effectiveness in patients excluded from trials because of prior failure on dupilumab. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.